Companies
/Healthcare
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
$22.51
▲ $0.00 (+0.00%) today
Markets closed · 7:51am ET
Today · % change
Fundamentals
Market Cap
$782.2M
52-Week Range
$15 – $27
About TRAXV
First Tracks Biotherapeutics, Inc. is a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. The company is headquartered in San Diego, California.